May 25, 2009
Having spent the past five years catching up to other industries in the deployment of enterprise software systems that link researchers and laboratories companywide, big drug firms are now starting to push data storage and processing onto the Internet. Pfizer, Eli Lilly & Co., Johnson & Johnson, and Genentech are among the drugmakers that are piloting into an emerging area of IT services called cloud computing.
Full story at Chemical & Engineering News
There are 0 discussion items posted.
|
Join the Discussion |
NVIDIA is telling everyone that the GK110, its new Kepler GPU aimed at supercomputing, is all about improving performance per watt. But the other driving theme behind the new architecture is reducing the GPU's reliance on its CPU host. How well it accomplishes both these goals areas could determine the success of the new chip in high performance computing.
Read more...
PGI, Cray, and CAPS enterprise are moving quickly to get their new OpenACC-supported compilers into the hands of GPGPU developers. At NVIDIA's GPU Technology Conference this week, there was plenty of discussion around the new HPC accelerator framework, and all three OpenACC compiler makers, as well as NVIDIA, were talking up the technology.
Read more...
NVIDIA has introduced its first Kepler-generation GPU product for high performance computing, and revealed some of the inner working of the new architecture. The announcement took place at the kickoff of the company's GPU Technology Conference taking place this week in San Jose, California.
Read more...